Neonatal Focal Limb Perfusion Compromise: An Integrated Clinical Approach To Diagnosis, Monitoring, And Management

Neonatal focal limb perfusion compromise is uncommon but potentially limb-threatening and occasionally life-threatening. It most often follows arterial instrumentation, thrombosis, vasospasm, or low-flow states, but the bedside problem is broader than arterial occlusion alone. Large-vessel obstruction, microvascular no-reflow, and reperfusion injury may coexist, and failure to distinguish these mechanisms can delay limb-salvage therapy. This manuscript presents a practical, journal-style synthesis designed for neonatal and multidisciplinary use. It integrates serial clinical examination with perfusion index (PI), Doppler ultrasonography, near-infrared spectroscopy (NIRS), and a staged therapeutic strategy that prioritizes anticoagulation, identifies when thrombolysis or surgery is required, and defines the role of adjuncts such as topical nitroglycerin, pentoxifylline, contralateral limb warming, N-acetylcysteine, and maintenance-phase aspirin [1-11]. The central thesis is that bedside trend analysis—particularly comparison of affected-limb PI with the contralateral limb—is more useful than any isolated measurement. A clinically usable algorithm, pharmacologic summary, monitoring framework, case-based PI trend interpretation, and multidisciplinary role allocation are provided. This integrated model is intended to reduce diagnostic delay, improve escalation decisions, and bridge the gap between thrombosis guidelines and day-to-day neonatal limb care.